AU2002360156A1 - Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents - Google Patents

Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents

Info

Publication number: AU2002360156A1
Authority: AU; Australia
Prior art keywords: variants; preparation; growth factor; therapeutic use; hepatocyte growth
Prior art date: 2001-10-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002360156A

Inventor

Tatiana Merkoulova-Rainon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

IVS Institut des Vaisseaux et du Sang

Original Assignee

IVS Institut des Vaisseaux et du Sang

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-31

Filing date

2002-10-30

Publication date

2003-05-12

2002-10-30 Application filed by IVS Institut des Vaisseaux et du Sang filed Critical IVS Institut des Vaisseaux et du Sang

2003-05-12 Publication of AU2002360156A1 publication Critical patent/AU2002360156A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU2002360156A 2001-10-31 2002-10-30 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents Abandoned AU2002360156A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0114146A FR2831540B1 (en)	2001-10-31	2001-10-31	ISOLATED PEPTIDE FROM THE HEPATOCYTA GROWTH FACTOR AND ITS VARIANTS, METHOD OF PREPARATION AND THERAPEUTIC USE AS ANTIANGIOGENIC AGENTS
FR01/14146		2001-10-31
PCT/FR2002/003739 WO2003038095A2 (en)	2001-10-31	2002-10-30	Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents

Publications (1)

Publication Number	Publication Date
AU2002360156A1 true AU2002360156A1 (en)	2003-05-12

Family

ID=8868969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002360156A Abandoned AU2002360156A1 (en)	2001-10-31	2002-10-30	Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents

Country Status (6)

Country	Link
EP (1)	EP1442121A2 (en)
JP (1)	JP2005508637A (en)
AU (1)	AU2002360156A1 (en)
CA (1)	CA2465714A1 (en)
FR (1)	FR2831540B1 (en)
WO (1)	WO2003038095A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1952826A4 (en) *	2005-10-24	2011-05-18	Fujifilm Ri Pharma Co Ltd	Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor
US9611297B1 (en)	2016-08-26	2017-04-04	Thrasos Therapeutics Inc.	Compositions and methods for the treatment of cast nephropathy and related conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6566098B1 (en) *	1990-09-14	2003-05-20	The United States Of America As Represented By The Department Of Health And Human Services	DNA encoding truncated hepatocyte growth factor variants
CA2327382C (en) *	1998-04-28	2012-12-18	Toshikazu Nakamura	Neovascularization inhibitors
WO2001044294A2 (en) *	1999-12-15	2001-06-21	Entremed, Inc.	Compositions and methods for inhibiting endothelial cell proliferation

2001
- 2001-10-31 FR FR0114146A patent/FR2831540B1/en not_active Expired - Fee Related
2002
- 2002-10-30 AU AU2002360156A patent/AU2002360156A1/en not_active Abandoned
- 2002-10-30 CA CA002465714A patent/CA2465714A1/en not_active Abandoned
- 2002-10-30 WO PCT/FR2002/003739 patent/WO2003038095A2/en not_active Ceased
- 2002-10-30 JP JP2003540360A patent/JP2005508637A/en active Pending
- 2002-10-30 EP EP02795357A patent/EP1442121A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
JP2005508637A (en)	2005-04-07
FR2831540B1 (en)	2004-07-09
FR2831540A1 (en)	2003-05-02
WO2003038095A2 (en)	2003-05-08
EP1442121A2 (en)	2004-08-04
WO2003038095A3 (en)	2003-12-24
CA2465714A1 (en)	2003-05-08

Similar Documents

Publication	Publication Date	Title
AU2002363236A1 (en)	2003-05-12	Compounds, pharmaceutical compositions and methods of use therefor
AU2002340999A1 (en)	2003-05-22	Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2002322719A1 (en)	2003-02-17	Delivery of therapeutic capable agents
AU2002314466A1 (en)	2002-10-15	Withasol and methods of use
IS6531A (en)	2002-08-28	Methods for the preparation of clariodorphysin and clariodorphysin intermediates, essentially oxymorphic clariforomycin and preparations containing it
AU2002240359A1 (en)	2002-08-28	Pharmaceutical composition for the treatment of alopecia
AU2002359618A1 (en)	2003-06-23	Medicinal compositions and therapeutic methods
AU2002363938A1 (en)	2003-06-10	Methods and use of motoneuronotropic factors
AU2003246614A1 (en)	2004-01-19	Novel use of lipopeptide preparations
AU2002341828A1 (en)	2003-04-01	Enhanced proteins and methods for their use
AU2002360156A1 (en)	2003-05-12	Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
AU2002320079A1 (en)	2002-12-23	Vaccines, immunotherapeutics and methods of using the same
IL158587A0 (en)	2004-05-12	Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
AU2002229870A1 (en)	2003-02-06	Mikanolide derivatives, their preparation and therapeutic uses
AU2002319620A1 (en)	2003-02-17	Functional site profiles for proteins and methods of making and using the same
AU2002351798A1 (en)	2003-05-12	Methods and dosage forms for improving the bioavailability of therapeutic agents
AU2002252773A1 (en)	2002-06-11	Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2001268903A1 (en)	2001-12-11	Hexaglucal compound and the use and the methods of preparing them
AU2001277750A1 (en)	2002-02-25	Use of polypeptide
AU2002359898A1 (en)	2003-07-24	Preparation of alpha-diimines
AU2002214598A1 (en)	2002-04-29	Claspin proteins and methods of use thereof
ZA200309774B (en)	2005-03-17	Methods for preparation and use of psorospermin analogs.
AU2001298075A1 (en)	2003-06-10	Composition for the regeneration and stimulation of hair growth
GB0108923D0 (en)	2001-05-30	Administration of beneficial substances
AU2002257630A1 (en)	2002-09-24	Human mrp5-like protein

Legal Events

Date	Code	Title	Description
2004-07-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase